检索结果 - Helen Berryman

Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors 由 Apostolia M. Tsimberidou, Philip Beer, Carrie Cartwright, Cara Haymaker, Henry Hiep Vo, Simin Kiany, Alexander Cecil, James Dow, Kemal Haque, Franck A. Silva, Lucy Coe, Helen Berryman, Elisabeth A. Bone, Graciela M. Nogueras‐González, David Vining, Hilary McElwaine-Johnn, Ignacio I. Wistuba